Lital has significant experience in the biotech industry, with a focus on drug development, from preclinical studies, through the regulatory submission process, and into the clinic. Lital has overseen SpliSense’s main program from the preclinical stage into the clinic and is currently managing all the company’s clinical and regulatory activities.
Previously, she was the Head of Preclinical Operations at Entera Bio, managing their lead program through IND submission.
Lital holds an MSc in Biotechnology and graduated with honors from the Hebrew University of Jerusalem.